Company profile: EncrypGen
1.1 - Company Overview
Company description
- Provider of next-generation software for genomic data, empowering patients and donors and facilitating health, business, and science.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to EncrypGen
Immunai
HQ: United States
Website
- Description: Provider of immunology mapping and reprogramming solutions leveraging machine learning and software engineering, including AMICA—a comprehensive immune cell knowledge base integrating clinico-genomic data; single-cell analysis and functional genomics; and drug discovery and development support from target discovery and validation through compound validation and clinical trial optimization, with biopharma and academic partnerships contributing data back to AMICA.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Immunai company profile →
Strateos
HQ: United States
Website
- Description: Provider of SaaS-based robotic solutions for biology labs, offering the Strateos Cloud Lab for remote experiment design, execution, and analysis; lab automation software to manage instruments and workflows via the cloud; design and build services for modular smart labs; AI for drug discovery; discovery biology services; and automated small molecule drug discovery workflows.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Strateos company profile →
BBK Worldwide
HQ: United States
Website
- Description: Provider of patient recruitment marketing and clinical trial support for the pharmaceutical, biotechnology, and medical device industries, offering strategy and research for trial enrollment, creative recruitment campaigns, targeted outreach across media channels, apps, and influencers, site success services (prescreening, referral management, communications), participant travel logistics with concierge support, and global participant payment reimbursement with instant access to funds.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BBK Worldwide company profile →
Genesis Therapeutics
HQ: United States
Website
- Description: Provider of AI-enabled small molecule drug discovery solutions, including GEMS for generative and predictive design of novel and challenging targets; Dynamic PotentialNet for potency and ADMET prediction using deep learning and molecular simulations; a Molecular Generation Engine to explore chemical space; and AI platform collaborations with Eli Lilly and Genentech.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Genesis Therapeutics company profile →
Inova
HQ: France
Website
- Description: Provider of digital partnering solutions for the biopharma and life sciences industry, offering Inpart, a platform connecting academic researchers, universities and industry to facilitate collaboration and commercialization; Connect, an algorithm- and machine learning–based matchmaking platform aligning biotech assets with biopharma needs; Deal, a CRM for biopharma partnering; and Event, software for managing in-person or online life science conferences and meetings.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Inova company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for EncrypGen
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to EncrypGen
2.2 - Growth funds investing in similar companies to EncrypGen
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for EncrypGen
4.2 - Public trading comparable groups for EncrypGen
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →